Robert G Clifton, Jr

Title: The Innovations of Robert G Clifton, Jr.

Introduction

Robert G Clifton, Jr. is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of bis-naphthalimides. His work focuses on innovative processes that have the potential to impact cancer treatment in mammals.

Latest Patents

Robert G Clifton, Jr. holds a patent for "Processes for preparing bis-naphthalimides containing amino-acid derived." This invention includes bis-naphthalimides such as 2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]-bis[5-nitro-1H-benz[de]isoquinoline-1,3(2H)-dione] and 2,2'-[1,2-ethanediylbis[imino(2-methyl-2,1-ethanediyl)]]-bis[5-nitro-1H-benz[de]isoquinoline-1,3(2H)-dione]. The patent outlines processes for their preparation, pharmaceutical compositions containing them, and methods of using them to treat cancer.

Career Highlights

Robert G Clifton, Jr. is associated with the DuPont Merck Pharmaceutical Company, where he has been instrumental in advancing pharmaceutical research and development. His innovative approaches have contributed to the company's reputation for excellence in the pharmaceutical industry.

Collaborations

Throughout his career, Robert has collaborated with notable colleagues such as Jung-Hui Sun and Jose Ricardo Matos. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Robert G Clifton, Jr. exemplifies the spirit of innovation in the pharmaceutical field. His contributions, particularly in cancer treatment, highlight the importance of research and development in improving health outcomes. His work continues to inspire future advancements in medicine.